Efficacy of a Newcastle Disease Vaccine Developed
from Korean Strain NDRL0901 in Protecting against Recently Emerged
Newcastle Disease Viruses in Southeast Asia
JY Kim1,2, HJ Lee1,3, S Kim1,3, SC Jung3 and
KS Choi1,3*
1OIE
Reference Laboratory for Newcastle Disease; 2Veterinary Drugs and Biologics Division;3Avian Disease ResearchDivision, Animal and
Plant Quarantine Agency, 177 Hyeokshin 8-ro, Gimcheon39660,
Republic of Korea *Corresponding author: kchoi0608@korea.kr
Abstract
New Newcastle disease viruses (NDVs) have been
circulating among poultry flocks in several Southeast (SE) Asian countries since
the mid-2000s. This study analyzes whether the NDV vaccine strain, NDRL0901,
protects against genotype VIIh of NDV. The efficacy of
the NDRL0901 vaccine was tested in week-old and three-week-old specific pathogen
free (SPF) chickens. Week-old chickens that had been vaccinated had geometric
mean hemagglutination inhibition (HI) titers of 24.1 to 24.7
two weeks after vaccination. The vaccinated birds were completely
protected against potentially fatal clinical disease from both the MY3519/2010
and VN5/2007 NDV strains, which were administered via eye drops. No virus was
detected in the vaccinated birds, regardless of the challenge virus. When
three-week-old SPF chickens were vaccinated, the birds had geometric mean HI
titers of 26.3 two weeks after vaccination. The NDRL0901 vaccine
provided complete clinical protection against fatal challenges from the NDV
isolate, KN5/2011, which was administered via the intramuscular route. No virus
shedding was detected in the vaccinated birds after administration of the
challenge virus. Our results indicate that locally developed NDV vaccines using
NDRL0901 vaccine strain could provide complete protection against the emergent
NDV genotype VII in SE Asia.
Key words:
Newcastle disease vaccine, Newcastle disease
virus,
Protection, Southeast (SE) Asia